H.C. Wainwright raises Savara stock price target to $8 on larger patient pool
H.C. Wainwright has increased its price target for Savara's stock to $8, citing a larger patient pool as a key factor.
WPN Brief
H.C. Wainwright has increased its price target for Savara's stock to $8, citing a larger patient pool as a key factor.
Ask WPN AI